...
首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.
【24h】

Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.

机译:后处理可通过亚型特异性KATP通道激活来防止人类内皮缺血再灌注损伤,并通过抑制线粒体通透性过渡孔来模拟。

获取原文
获取原文并翻译 | 示例

摘要

AIMS: Intermittent early reperfusion (ischaemic postconditioning; PostC) reduces ischaemia-reperfusion (IR) injury. Using an in vivo model of endothelial IR injury in humans, we sought to determine the role of K(ATP) channels in PostC and whether inhibition of the mitochondrial permeability transition pore (mPTP) at the onset of reperfusion protected against endothelial IR injury. METHODS AND RESULTS: Endothelial function (EF) in healthy volunteers was assessed using vascular ultrasound to measure the percentage increase in the diameter of the brachial artery in response to reactive hyperaemia [flow-mediated dilatation (FMD)]. In resistance vessels, venous occlusion plethysmography was used to measure the dilator response to acetylcholine (ACh) [area under ACh dose-response curve (ACh AUC)]. Measurements were made before and after IR injury. Ischaemic postconditioning consisted of three 10 s cycles of alternating ischaemia and reperfusion in the first minute of reperfusion. Oral glibenclamide and glimepiride were used to determine the role of K(ATP) channel subtypes in PostC. Intra-arterial cyclosporine was used to determine the role of mPTP in endothelial IR injury. Ischaemia-reperfusion reduced EF in the brachial artery (FMD 7.1 +/- 0.9% pre-IR, 2.8 +/- 0.4% post-IR; P < 0.001) and resistance vessels [ACh AUC (x10(4)) 2.1 +/- 0.4 pre-IR, 1.5 +/- 0.2 post-IR; P < 0.05]. Ischaemic postconditioning preserved EF in the brachial artery [FMD 6.8 +/- 0.9% (P < 0.001 vs. post-IR)] and resistance vessels [ACh AUC (x10(4)) 1.9 +/- 0.2 (P < 0.001 vs. post-IR)]. Protection by PostC was abolished by glibenclamide in the brachial artery [FMD 3.3 +/- 0.2% (P < 0.001 vs. post-IR + PostC)] and in resistance vessels [ACh AUC (x10(4)) 1.1 +/- 0.2 (P < 0.001 vs. post-IR + PostC)], whereas glimepiride had no effect. Cyclosporine preserved EF after IR injury in the resistance vessels [ACh AUC (x10(4)) 1.4 +/- 0.2 post-IR vs. 2.2 +/- 0.3 post-IR + cyclosporine; P < 0.05]. CONCLUSION: Protection by PostC against endothelial IR injury in humans depends on K(ATP) channel activation and is mimicked by inhibition of the mPTP at reperfusion.
机译:目的:间歇性早期再灌注(缺血后处理; PostC)减少缺血再灌注(IR)损伤。使用人类内皮IR损伤的体内模型,我们试图确定K(ATP)通道在PostC中的作用,以及在再灌注开始时抑制线粒体通透性转换孔(mPTP)是否能保护内皮免受IR损伤。方法和结果:使用血管超声评估健康志愿者的内皮功能(EF),以测量反应性充血[流量介导的扩张(FMD)]引起的肱动脉直径增加的百分比。在阻力血管中,静脉阻塞体积描记法用于测量对乙酰胆碱(ACh)[ACh剂量-反应曲线(ACh AUC)下的面积]的扩张剂反应。在IR损伤之前和之后进行测量。缺血后处理由再灌注的第一分钟的三个10 s交替的局部缺血和再灌注循环组成。口服格列本脲和格列美脲用于确定PostC中K(ATP)通道亚型的作用。动脉内环孢菌素用于确定mPTP在内皮IR损伤中的作用。缺血再灌注降低了肱动脉的EF(FMD在IR前为7.1 +/- 0.9%,IR后为2.8 +/- 0.4%; P <0.001)和耐药性血管[ACh AUC(x10(4))2.1 + / -IR前0.4,IR后1.5 +/- 0.2; P <0.05]。缺血后处理在肱动脉[FMD 6.8 +/- 0.9%(P <0.001 vs. IR)中]和耐药血管[ACh AUC(x10(4))1.9 +/- 0.2(P <0.001 vs.后IR]]。肱动脉[FMD 3.3 +/- 0.2%(P <0.001 vs. IR + PostC)]和耐药血管[ACh AUC(x10(4))1.1 +/- 0.2]中的格列本脲取消了PostC的保护。 (与IR + PostC相比,P <0.001)],而格列美脲则无作用。 IR损伤后,环孢霉素在耐药性血管中保留了EF [ACh AUC(x10(4))IR后为1.4 +/- 0.2,而IR +环孢素为2.2 +/- 0.3; P <0.05]。结论:PostC对人的内皮IR损伤的保护取决于K(ATP)通道的激活,并通过在再灌注时抑制mPTP来模仿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号